BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/10/2025 2:35:25 AM | Browse: 1 | Download: 0
| Category |
Anesthesiology |
| Manuscript Type |
Editorial |
| Article Title |
Does anesthesia choice shape oncologic destiny in gastric cancer surgery?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Oguzhan Arun and Funda Arun |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Oguzhan Arun, MD, PhD, Professor, Department of Anesthesiology and Reanimation, Selcuk University Faculty of Medicine, Alaaddin Keykubat Kampus, Konya 42130, Türkiye. oguzarun@selcuk.edu.tr |
| Key Words |
Anesthesia; Gastric cancer; Propofol; Sevoflurane; Total intravenous anesthesia |
| Core Tip |
Anesthetic choice in gastric cancer surgery extends beyond technical preference, potentially influencing immune function, stress response, and oncologic outcomes. Propofol-based total intravenous anesthesia demonstrates promising molecular and clinical anti-tumor properties-modulating microRNAs, enhancing natural killer cell activity, and improving post-operative recovery-while sevoflurane, though traditionally considered neutral, shows emerging immunoregulatory and gene-expression effects. Current evidence, including the recent Wang et al study, suggests both agents yield comparable perioperative safety and survival outcomes; however, their distinct molecular profiles highlight anesthesia as a modifiable element in personalized cancer care. Future biomarker-driven research is essential to clarify when and how anesthetic selection might influence long-term oncologic prognosis. |
| Citation |
Arun O, Arun F. Does anesthesia choice shape oncologic destiny in gastric cancer surgery? World J Gastrointest Oncol 2025; In press |
 |
Received |
|
2025-10-29 05:42 |
 |
Peer-Review Started |
|
2025-10-29 05:43 |
 |
First Decision by Editorial Office Director |
|
2025-11-06 08:51 |
 |
Return for Revision |
|
2025-11-06 08:51 |
 |
Revised |
|
2025-11-17 14:52 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-12-09 02:39 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-12-10 02:35 |
 |
Articles in Press |
|
2025-12-10 02:35 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345